“Caudal to cranial” versus “medial to lateral” approach in laparoscopic right hemicolectomy with complete mesocolic excision for the treatment of stage II and III colon cancer: perioperative outcomes and 5-year prognosis

被引:0
|
作者
Xiaojiang Yi
Weilin Liao
Bosen Zhu
Xiaochuang Feng
Hongming Li
Chuangqi Chen
Manzhao Ouyang
Dechang Diao
机构
[1] Southern Medical University,The Second School of Clinical Medicine
[2] Southern Medical University (The First People’s Hospital of Shunde Foshan),Department of Gastrointestinal Surgery, Shunde Hospital
[3] The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Department of Colorectal (Tumor) Surgery, Guangdong Provincial Hospital of Chinese Medicine
[4] The Second Affiliated Hospital of Guangdong Medical University,Department of Gastroenteroanal Surgery
[5] The First Affiliated Hospital of Sun Yat-sen University,Department of Colorectal Surgery
来源
Updates in Surgery | 2023年 / 75卷
关键词
Laparoscopic right hemicolectomy; Caudal to cranial; Medial to lateral; 5-year prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to compare the “caudal to cranial” (CC) versus “medial to lateral” (ML) approach for laparoscopic right hemicolectomy. Pertinent data from all patients with stage II and III between January 2015 and August 2017 were entered into a retrospective database. A total of 175 patients underwent the ML (N = 109) or CC approach (N = 66). Patient characteristics were equivalent between groups. The CC group showed a shorter surgical time 170.00 (145.00, 210.00) vs. (206.50 (178.75, 226.25) min) than the ML group (p < 0.001). The time to oral intake was shorter in the CC group than in the ML group ((3.00 (1.00, 4.00) vs. 3.00 (2.00, 5.00) days; p = 0.007). For the total harvested lymph nodes, there was no statistical significance between the CC group 16.50 (14.00, 21.25) and the ML group 18.00 (15.00, 22.00) (p = 0.327), and no difference was found in the positive harvested lymph nodes (0 (0, 2.00) vs. 0 (0, 1.50); p = 0.753). Meanwhile, no differences were found in other perioperative or pathological outcomes, including blood loss and complications. For 5-year prognosis, overall survival rates were 75.76% in the CC group and 82.57% in the ML group (HR 0.654, 95% CI 0.336–1.273, p = 0.207); disease-free survival rates were 80.30% in the CC group and 85.32% in the ML group (HR 0.683, 95% CI 0.328–1.422, p = 0.305). Both approaches were safe and feasible and resulted in excellent survival. The CC approach was beneficial in terms of the surgical time and time to oral intake.
引用
收藏
页码:1149 / 1160
页数:11
相关论文
共 37 条
  • [31] 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study (vol 20, pg 1556, 2019)
    Bertelsen, C. A.
    Neuenschwander, A. U.
    Jansen, J. E.
    LANCET ONCOLOGY, 2020, 21 (08): : E372 - E372
  • [32] Complete mesocolic excision with D3 lymph node dissection in laparoscopic colectomy for stages II and III colon cancer: long-term oncologic outcomes in 168 patients
    J. W. Shin
    A. H. Y. Amar
    S. H. Kim
    J. M. Kwak
    S. J. Baek
    J. S. Cho
    J. Kim
    Techniques in Coloproctology, 2014, 18 : 795 - 803
  • [33] Complete mesocolic excision with D3 lymph node dissection in laparoscopic colectomy for stages II and III colon cancer: long-term oncologic outcomes in 168 patients
    Shin, J. W.
    Amar, A. H. Y.
    Kim, S. H.
    Kwak, J. M.
    Baek, S. J.
    Cho, J. S.
    Kim, J.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (09) : 795 - 803
  • [34] A novel mixed cephalic-medial-caudal approach for laparoscopic complete mesocolic excision plus D3 lymphadenectomy including extended lymph node dissection of the subpyloric lymph node (no. 206): laparoscopic extended right hemicolectomy with preserved right gastroepiploic vessels-a video vignette
    Wang, Ye
    Chen, Bin
    Cai, Huajun
    Li, Shoufeng
    Pan, Zhen
    Peng, Tengyi
    Chen, Jackie
    Liu, Xing
    Zhuang, Jinfu
    Guan, Guoxian
    COLORECTAL DISEASE, 2025, 27 (02)
  • [35] Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
    Xu, Lai
    Su, Xiangqian
    He, Zirui
    Zhang, Chenghai
    Lu, Junyang
    Zhang, Guannan
    Sun, Yueming
    Du, Xiaohui
    Chi, Pan
    Wang, Ziqiang
    Zhong, Ming
    Wu, Aiwen
    Zhu, Anlong
    Li, Fei
    Xu, Jianmin
    Kang, Liang
    Suo, Jian
    Deng, Haijun
    Ye, Yingjiang
    Ding, Kefeng
    Xu, Tao
    Zhang, Zhongtao
    Zheng, Minhua
    Xiao, Yi
    LANCET ONCOLOGY, 2021, 22 (03): : 391 - 401
  • [36] Short-term clinical outcomes from a randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision for stage II,III colorectal cancer (CRC): Japan Clinical Oncology Group study JCOG0404 (NCT00147134).
    Nishizawa, Yusuke
    Saito, Norio
    Inomata, Masafumi
    Etoh, Tsuyoshi
    Kitano, Seigo
    Katayama, Hiroshi
    Mizusawa, Junki
    Yamamoto, Seiichiro
    Kinugasa, Yusuke
    Fujii, Shoichi
    Konishi, Fumio
    Saida, Yoshihisa
    Shimada, Yasuhiro
    Moriya, Yoshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] A randomized controlled trial to evaluate laparoscopic versus open complete mesocolic excision (CME) for stage II, III colorectal cancer (CRC): First efficacy results from Japan Clinical Oncology Group Study JCOG0404.
    Inomata, Masafumi
    Katayama, Hiroshi
    Mizusawa, Junki
    Watanabe, Masahiko
    Sugihara, Kenichi
    Konishi, Fumio
    Yamamoto, Seiichiro
    Saito, Shuji
    Fujii, Shoichi
    Saida, Yoshihisa
    Hasegawa, Hirotoshi
    Etoh, Tsuyoshi
    Moriya, Yoshihiro
    Kitano, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)